Joe Verghese
<p>Dr. Joe Verghese graduated from St. Johns Medical College, Bangalore, India in 1989. He did his postgraduate training in Internal Medicine and Neurology in United Kingdom. He completed his Neurology residency at the Albert Einstein College of Medicine, Bronx, NY in 1998. He did his fellowship training in Neurophysiology as well as Aging & Dementia in 1999 at the same institution. He received a Master of Science degree in Clinical Research Methods with Distinction in 2001. Dr Verghese is board-Certified in Neurology.</p>
<p>Dr. Verghese is Professor of Neurology and Medicine, Murray D. Gross Memorial Faculty Scholar in Gerontology, and Director, Resnick Gerontology Center at Einstein. He is the Chief of the Division of Cognitive and Motor Aging (Neurology), and former Chief of Geriatrics (Medicine 2012-2023).</p>
<p>Dr. Verghese is a recipient of the Beeson award from the National institute on Aging as well as national awards from the American Geriatrics Society and the Gerontological Society of America. His research interest is the effects of disease and aging on mobility and cognition in older adults. He has over 300 peer-reviewed publications, and several current and past federally funded grants in this area. His current projects include non-pharmacological interventions to prevent dementia, the role of divided attention tasks such as walking while talking in predicting outcomes such as disability and cognitive decline, pre-dementia syndromes (Motoric Cognitive Risk syndrome), and global health studies.</p>
<p class="MsoNormal" style="line-height: 15.6pt;">Dr. Joe Verghese is a board-certified neurologist and expert on aging who assesses how diseases and aging affect cognitive ability and mobility in older adults. Among his current projects, he is evaluating the effectiveness of a non-invasive brain stimulation technique intended to alleviate symptoms of Alzheimer’s disease and improve brain function. He is also conducting studies across the world to identify the causes of cognitive impairment and risk factors for Alzheimer’s disease and dementia.</p>
<p class="MsoNormal" style="line-height: 15.6pt;">Dr. is a recipient of the Beeson award from the National Institute on Aging and the Outstanding Scientific Achievement for Clinical Investigation Award from the American Geriatrics Society. He has over 250 publications in his areas of expertise.</p>
Dr. Verghese focuses on the care of older adults with cognitive concerns.
Dr. Verghese’s research focus is the effects of disease and aging on mobility and cognition in older adults, and he leads several federally funded projects in these areas.
<p>Verghese J, Lipton RB, Katz MJ, Hall CB, Kuslansky G, Buschke H. Abnormality of Gait As A Predictor Of Non-Alzheimer Dementia. N Engl J Med 2002 ; 347: 1760-1767. Verghese J, Lipton RB, Katz MJ, Hall CB, Kuslansky G, Derby CA, Ambrose AF, Sliwinski M, Buschke H. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348: 2508-2516. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61: 1667-1672. Verghese J, Levalley A, Hall CB, Katz M, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community residing elderly. J Am Geriatr Soc 2006, 54(2):255-61. Holtzer R, Verghese J, Xue X, Lipton R. Cognitive processes related to gait velocity: Results from the Einstein Aging Study. Neuropsychology 2006; 20(2):215-23. Verghese J, LeValley A, Derby C, Kuslansky G, Katz M, Hall C, Buschke H, Lipton RB. Leisure Activities And The Risk of Amnestic Mild Cognitive Impairment In The Elderly. Neurology 2006; 66(6):821-7. Verghese J, Holtzer R, Lipton R, Wang C. Quantitative Gait Markers And Risk of Incident Falls in Older Adults. <em>J Gerontol Med Sci</em> 2009; 64: 896-901. Rolita L, Holtzer R, Wang C, Lipton RB, Derby CA, Verghese J. Homocysteine and Mobility in Older Adults. <em>J Am Geriatr Soc. 2010; 58:545-50.V</em>erghese J<strong>, </strong>Holtzer R. Walking the Walk While Talking: Cognitive Therapy for Mobility in Dementia? <em>Neurology 2010; 74:1938-9; </em>Verghese J, Wang C, Lipton RB, Holtzer R. Motoric cognitive risk syndrome and the risk of dementia. <em>Journal of Gerontology: Medical Sciences </em>2012<em><strong>; </strong></em>Verghese J, Noone ML, Johnson, B,<sup> </sup>Ambrose AF, Wang C, Buschke H, Pradeep VG, Salam KA, Shaji KS, Mathuranath PS. Picture Based Memory Impairment Screen For Dementia.<em> Journal of the American Geriatrics Society</em>, 2012; 60(11):2116-20. </p>
<p><em> </em></p>
<p>Joe Verghese, MBBS, MS, is Chief, Division of Cognitive and Motor Aging and Chief, Division of Geriatrics at Montefiore. He is the founding Director of the Montefiore-Einstein Center for the Aging Brain, an interdisciplinary cognitive assessment center. He is also Professor of Neurology and Medicine at our Albert Einstein College of Medicine. Dr. Verghese’s clinical focus is dementia and cognitive impairment.</p><p>In 1989, Dr. Verghese received his Bachelor of Medicine, Bachelor of Surgery at St. John’s Medical College in India. Dr. Verghese obtained his Membership in the Royal College of Physicians of Ireland (M.R.C.P.I) in 1994. From 1995 to 1999, Dr. Verghese trained at Albert Einstein College of Medicine. During this time, he completed a residency in neurology, becoming Chief Resident in his final year, as well as two fellowships---one in aging and dementia and one in neurophysiology.He then attended Albert Einstein College of Medicine, where he received his Master of Science with distinction in clinical research methods in 2001.</p><p>Expanding on his clinical specialties, Dr. Verghese’s research focuses on the effects of disease and aging on mobility and cognition in older adults. His work has been published in over 200 peer-reviewed journals, books and medical articles.</p><p>In 2010 and 2018, Dr. Verghese was named Mentor of the Year in the Clinical Research Training Program at Albert Einstein College of Medicine.</p><p>Dr. Verghese is board certified by the American Board of Neurology and Psychiatry. He is a member of numerous professional societies including the International Society to Advance Alzheimer’s Research and Treatment, the American Neurological Association, American Geriatrics Society and the National Clinical Research Forum.</p>